MedPath

The effect of Labetalol on bleeding during lumbar spine fusion surgery

Phase 2
Recruiting
Conditions
Bleeding rate during lumbar spine fusion surgery.
Ankylosing spondylitis
Registration Number
IRCT20160307026950N30
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
64
Inclusion Criteria

Patients 18 to 50 years
Candidate for lumbar spine fusion surgery
ASA Class I and II Anesthesia

Exclusion Criteria

History of any allergy to Labetalol
History of heart block
History of lung diseases such as asthma

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The amount of bleeding during the operation. Timepoint: After surgical incision until the end of the operation. Method of measurement: Counting the number of blood gases and measuring the amount of sucked blood.
Secondary Outcome Measures
NameTimeMethod
Heart Rate. Timepoint: Before surgery, during anesthesia, after anesthesia until the end of the operation, from the beginning of recovery to exit it. Method of measurement: ECG monitoring.;Blood Pressure. Timepoint: Preoperative time, anesthesia time, every 10 minutes from the start of the operation until the end of the recovery. Method of measurement: Barometer.;Percentage of arterial blood oxygen saturation. Timepoint: Before surgery, during anesthesia, after anesthesia until the end of the operation, from the beginning of recovery to exit it. Method of measurement: Pulse Oximeter.
© Copyright 2025. All Rights Reserved by MedPath